Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07713329Phase 2Completed
A Phase 2 trial of hydrogen peroxide, corticosteroids in parapneumonic pleural effusion, sponsored by Delta University for Science and Technology. Started Mar 2026; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07713329.